Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy

Analytical and Bioanalytical Chemistry

Volumn 407, Issue 9, 2015, Pages 2569-2579

  Liu, Jingping ^a   Wang, Chengshi ^a   Liu, Fang ^a   Lu, Yanrong ^a   Cheng, Jingqiu ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Inflammation; Metabonomic; NF B; Oxidative stress; Xanthine oxidase

Indexed keywords

BODY FLUIDS; CELL SIGNALING; DISEASES; MEDICAL PROBLEMS; MULTIVARIANT ANALYSIS; OXIDATIVE STRESS; PATHOLOGY; RATS;

DIABETIC NEPHROPATHY; INFLAMMATION; INFLAMMATORY RESPONSE; METABOLIC PROFILES; METABONOMICS; MULTIVARIATE DATA ANALYSIS; SIGNALING PATHWAYS; XANTHINE OXIDASE;

METABOLISM;

RATTUS;

ALLANTOIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; URIC ACID; XANTHINE OXIDASE;

ANIMAL; BLOOD; CHEMISTRY; DIABETIC NEPHROPATHY; ENZYMOLOGY; EVALUATION STUDY; HUMAN; IMMUNOLOGY; KIDNEY; MALE; METABOLISM; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; URINE;

ALLANTOIN; ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; URIC ACID; XANTHINE OXIDASE;

EID: 84938092527     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-015-8481-0     Document Type: Article

References (35)

1. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164-176
2. Stanton RC (2014) Clinical challenges in diagnosis and management of diabetic kidney disease. Am J Kidney Dis 63:S3-S21
3. Ritz E, Zeng XX, Rychlik I (2011) Clinical manifestation and natural history of diabetic nephropathy. Contrib Nephrol 170:19-27
4. Kanwar YS, Sun L, Xie P, Liu FY, Chen S (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395-423
5. Dronavalli S, Duka I, Bakris GL (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4:444-452
6. Singh DK, Winocour P, Farrington K (2011) Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7:176-184
7. Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature 455:1054-1056
8. Rezzi S, Ramadan Z, Fay LB, Kochhar S (2007) Nutritional metabonomics: applications and perspectives. J Proteome Res 6:513-525
9. Dieterle F, Riefke B, Schlotterbeck G, Ross A, Senn H, Amberg (2011) A NMR and MS methods for metabonomics. Methods Mol Biol 691:385-415
10. Makinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K, Groop PH, Ala-Korpela M (2008) 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 4:167
11. Hirayama A, Nakashima E, Sugimoto M, Akiyama S, Sato W, Maruyama S, Matsuo S, Tomita M, Yuzawa Y, Soga T (2012) Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem 404:3101-3109
12. Pena MJ, Lambers Heerspink HJ, Hellemons ME, Friedrich T, Dallmann G, Lajer M, Bakker SJ, Gansevoort RT, Rossing P, de Zeeuw D, Roscioni SS (2014) Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus. Diabet Med 31:1138-1147
13. Zhao L, Gao H, Lian F, Liu X, Zhao Y, Lin D (2011) 1H-NMR-based metabonomic analysis of metabolic profiling in diabetic nephropathy rats induced by streptozotocin. Am J Physiol Ren Physiol 300:F947-F956
14. Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2:2692-2703
15. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78:4430-4442
16. Wang D, Liu J, He S, Wang C, Chen Y, Yang L, Liu F, Ren Y, Tian H, Yang G, Liao G, Li L, Shi M, Yuan Y, Zhao J, Cheng J, Lu Y (2014) Assessment of early renal damage in diabetic rhesus monkeys. Endocrine 47:783-792
17. Bain JR, Stevens RD, Wenner BR, Ilkayeva O, Muoio DM, Newgard CB (2009) Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58:2429-2443
18. Liu J, Wang D, Chen Y, Sun H, He S, Wang C, Yang G, Shi M, Zhang J, Ren Y, Wang L, Lu Y, Cheng J (2013) 1H NMR-based metabonomic analysis of serum and urine in a nonhuman primate model of diabetic nephropathy. Mol Biosyst 9:2645-2652
19. Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E (2012) Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 35:99-104
20. Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH (2009) Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 58:1668-1671
21. George J, Struthers AD (2009) Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag 5:265-272
22. Doehner W, Landmesser U (2011) Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. Semin Nephrol 31:433-440
23. Marklund N, Ostman B, Nalmo L, Persson L, Hillered L (2000) Hypoxanthine, uric acid and allantoin as indicators of in vivo free radical reactions. Description of a HPLC method and human brain microdialysis data. Acta Neurochir (Wien) 142:1135-1141
24. Bravard A, Bonnard C, Durand A, Chauvin MA, Favier R, Vidal H, Rieusset J (2011) Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am J Physiol Endocrinol Metab 300:E581-E591
25. Desco MC, Asensi M, Marquez R, Martinez-Valls J, Vento M, Pallardo FV, Sastre J, Vina J (2002) Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 51:1118-1124
26. Rajesh M, Mukhopadhyay P, Batkai S, Mukhopadhyay B, Patel V, Hasko G, Szabo C, Mabley JG, Liaudet L, Pacher P (2009) Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy. J Cell Mol Med 13:2330-2341
27. Romagnoli M, Gomez-Cabrera MC, Perrelli MG, Biasi F, Pallardó FV, Sastre J, Poli G, Viña J (2010) Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats. Free Radic Biol Med 49:171-177
28. Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749-762
29. Tabak O, Gelisgen R, Erman H, Erdenen F, Muderrisoglu C, Aral H, Uzun H (2011) Oxidative lipid, protein, and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus. Clin Invest Med 34:E163-E171
30. Sun L, Hu W, Liu Q, Hao Q, Sun B, Zhang Q, Mao S, Qiao J, Yan X (2012) Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res 11:2937-2946
31. Elmarakby AA, Sullivan JC (2012) Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 30:49-59
32. Morgan MJ, Liu ZG (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21:103-115
33. Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, Roncal C, Johnson RJ, Nakagawa T (2009) Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice. Am J Physiol Ren Physiol 297:F481-F488
34. Baker RG, Hayden MS, Ghosh S (2011) NF-kappaB, inflammation, and metabolic disease. Cell Metab 13:11-22
35. Gloire G, Legrand-Poels S, Piette J (2006) NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 72:1493-1505